Key Milestone Reached by US Stem Cell Inc (OTCMKTS:USRM)

519

 

US Stem Cell Inc (OTCMKTS:USRM) we were referencing its work on Psoriasis treatment, which had reportedly achieved a massive reduction in the effects of the disease in a recent study.

Psoriasis is a disease that affects several million in the United States alone, with symptoms arising on the skin in the form of scaly ‘plaque’, with the scalp, knees, elbows, hands, and feet being the most commonly affected areas. With a success rate such as that which has been demonstrated in lab conditions, we have been eager to see USRM continue to develop this treatment.

This week also marked a huge milestone for US Stem Cell Inc (OTCMKTS:USRM) in the development of its business plans with the company having announced the opening its first USRM clinic in North Central Florida.

The U.S. Stem Cell Clinic of The Villages will offer alternatives to chronic pain management using USRM’s proprietary AdipocellTM product in a minimally invasive procedure utilizing a patient’s own (autologous) stem cells.  Medical director for the clinic will be Dr. Rosemary Daly, an interventional spine/pain management physician who is board certified in Anesthesiology and Pain Medicine.  Dr. Daly, who graduated from the New York College of Osteopathic Medicine, is also medical director for the Regenerative Wellness Clinic (RWC) in West Palm Beach, which is also in the USRM network of stem cell treatment centers.

“Expansion of our regenerative healing centers to The Villages is an opportunity to directly serve an active community that is very proactive about seeking ways to increase their quality of life,” said Dr. Kristin Comella, USRM’s Chief Science Officer.   “We look forward to serving this vibrant community by offering holistic stem cell therapy for neurological, autoimmune, orthopedic and degenerative conditions.”

 

“Our vision at USRM has always been to expand access of autologous stem cell treatments to as many people as possible,” said Mike Tomas, President and CEO of U.S. Stem Cell, Inc.  “Now that we are seeing a steady increase in demand for stem cell therapy, which has driven our progress in reaching milestones that allow for growth, we are ready to continue expanding our network of clinics.  The clinic at The Villages represents that next step.”

USRM has been instrumental in performing more than 10,000 stem cell procedures in the past 19 years for a variety of indications.  USRM also trains and certifies physicians in stem cell therapy — to date, more than 700+ physicians worldwide — and has a growing network of 288 physicians and clinics utilizing the USRM technologies, protocols and products. Dr. Comella continues to enhance USRM’s visibility worldwide for autologous stem cell treatments, as well as developing and bringing USRM’s proprietary AdipocellTM product to market: a stem cell kit which enables physicians to separate potent stem cells from a patient’s own fat cells, which are harvested and reinserted in a minimally invasive, two-hour procedure without general anesthesia.

Dr. Comella is also well published in the scientific literature and has been recognized by her peers as an innovator and world leader in the development and clinical practice of stem cell products and therapies. Most recently, she presented a summary of peer-reviewed publications at the Academy of Regenerative Practices Conference in Weston, Florida. (Source: PR Newswire)

We’re anxious to follow the company’s continued progress with opening its first brick and mortar location, but as we’ve stated previously, our true interest lies in the company’s ground breaking development of its proven psoriasis treatment into a novel product. Just stay locked to Street Register for updates, and we’ll deliver important developments on USRM as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!

Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in USRM stock, short or long.

 

LEAVE A REPLY